ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.5075-?_5193+?dup119

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000456282 SCV000563929 pathogenic Hereditary breast ovarian cancer syndrome 2016-11-29 criteria provided, single submitter clinical testing This variant is a gross duplication of the genomic region encompassing exons 17-18 of the BRCA1 gene. While the exact position of the duplicated exons cannot be determined from this data, the duplicated copy of this region is likely in tandem and may result in an absent or disrupted protein product. Loss-of-function variants including gross alterations in BRCA1 are known to be pathogenic. Duplications of exons 17-18 have been reported in the literature in individuals with personal and/or family history of breast cancer (PMID: 16551709, 16724249, 16644204, 22544547). While the breakpoints are unknown, a duplication of exons 17-18 was reported as a recurrent large rearrangement among individuals of African ancestry (PMID: 22544547). In the literature, duplication of exons 17-18 is also known as duplication of exons 18-19 by alternative exon numbering. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.